| scholarly article | Q13442814 |
| P50 | author | Yana Pikman | Q44008671 |
| Gabriela Alexe | Q59440963 | ||
| Kimberly Stegmaier | Q59441052 | ||
| Nina Fenouille | Q59441180 | ||
| Frédéric Luciano | Q30419950 | ||
| P2093 | author name string | Qing Li | |
| Yi Zhang | |||
| Richard M Stone | |||
| Ilene Galinsky | |||
| Patrick Auberger | |||
| Michael T Hemann | |||
| Archibald S Perkins | |||
| Daniel J DeAngelo | |||
| Michael R Burgess | |||
| Kevin Shannon | |||
| Alexandre Puissant | |||
| Lina Benajiba | |||
| Issam Ben-Sahra | |||
| Christopher F Bassil | |||
| Azucena Ramos | |||
| Amy S Conway | |||
| P2860 | cites work | TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions | Q21999527 |
| SYK is a critical regulator of FLT3 in acute myeloid leukemia | Q24337247 | ||
| Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis | Q24527330 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria | Q24595940 | ||
| The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate | Q24605258 | ||
| RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group | Q27851623 | ||
| Prognostic relevance of integrated genetic profiling in acute myeloid leukemia | Q27851726 | ||
| Cancer cell metabolism: one hallmark, many faces. | Q38046274 | ||
| Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities | Q38116645 | ||
| The role of EVI1 in myeloid malignancies | Q38185179 | ||
| EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments | Q39190922 | ||
| Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells. | Q39232300 | ||
| Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. | Q39953712 | ||
| Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo. | Q41036166 | ||
| Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. | Q41983843 | ||
| Densely interconnected transcriptional circuits control cell states in human hematopoiesis | Q42654933 | ||
| Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. | Q44808698 | ||
| Arginine addiction in AML. | Q48165889 | ||
| Creatine kinase: the reactive cysteine is required for synergism but is nonessential for catalysis | Q72838514 | ||
| Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation | Q75447880 | ||
| High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities | Q83822325 | ||
| Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia | Q84596053 | ||
| Visualizing gene-set enrichment results using the Cytoscape plug-in enrichment map | Q84855688 | ||
| edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
| Creatine and creatinine metabolism | Q28140735 | ||
| Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration | Q28264933 | ||
| IDH mutation impairs histone demethylation and results in a block to cell differentiation | Q29305058 | ||
| PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
| RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome | Q29547458 | ||
| GenePattern 2.0 | Q29614171 | ||
| Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma | Q29614552 | ||
| Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation | Q29615366 | ||
| RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia | Q29617201 | ||
| Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues | Q33344596 | ||
| Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. | Q33716402 | ||
| Enrichment map: a network-based method for gene-set enrichment visualization and interpretation | Q33749961 | ||
| The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia | Q34156754 | ||
| Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis | Q34338923 | ||
| Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations | Q34471702 | ||
| Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus | Q34667782 | ||
| Preclinical efficacy of MEK inhibition in Nras-mutant AML. | Q34737521 | ||
| Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia | Q34796524 | ||
| Germline SDHB mutations and familial renal cell carcinoma. | Q34814012 | ||
| Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy | Q34924245 | ||
| Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome | Q34930673 | ||
| Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. | Q35561304 | ||
| Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity | Q35669072 | ||
| Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors | Q35750824 | ||
| MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. | Q35898171 | ||
| Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi | Q36088050 | ||
| Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia | Q36137651 | ||
| Prediction of genomic functional elements. | Q36528837 | ||
| Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia | Q36591394 | ||
| Succinate dehydrogenase expression in breast cancer. | Q37009756 | ||
| Highly parallel identification of essential genes in cancer cells | Q37068513 | ||
| Evi-1 as a critical regulator of leukemic cells | Q37763616 | ||
| Therapeutic advances in acute myeloid leukemia | Q37827282 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 301-313 | |
| P577 | publication date | 2017-02-13 | |
| P1433 | published in | ??? | Q1633234 |
| P1476 | title | The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia | |
| P478 | volume | 23 |
| Q58617350 | Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML |
| Q96131649 | Creatine metabolism: energy homeostasis, immunity and cancer biology |
| Q96302631 | Detachment of cell sheets from clinically ubiquitous cell culture vessels by ultrasonic vibration |
| Q89509869 | EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma |
| Q64147072 | EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 association |
| Q64109908 | Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism |
| Q91996647 | Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia |
| Q46113055 | Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras. |
| Q33758448 | Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancer |
| Q95279750 | Pathological processes in aqueous humor due to iris atrophy predispose to early corneal graft failure in humans and mice |
| Q89758359 | Sleeve Gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss |
| Q58743792 | Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression |
| Q97643506 | The creatine-phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis |
Search more.